SCHEMBL10690984

SCHEMBL10690984

CCOC(=O)c1cc(=O)c2ccc(O[Si](C)(C)C)cc2o1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 3/20 0.69
SLC2A1 P11166 1/20 0.68
KDM4E B2RXH2 3/20 0.57
MAOB P27338 2/20 0.57
ALDH1A1 P00352 1/20 0.52
MAPT P10636 2/20 0.49
GAA P10253 1/20 0.49
MAPK1 P28482 1/20 0.46
TNKS O95271 1/20 0.46
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
GPR35 Q9HC97 1/20 0.44
RAB9A P51151 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TP53 P04637 1/20 0.44
THRB P10828 1/20 0.44
LOXL2 Q9Y4K0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5322779 0.87 KDM4E (0.76) AKR1B1SLC2A1KDM4EMAOBALDH1A1
SCHEMBL432503 0.87 SLC2A1 (0.78) AKR1B1SLC2A1KDM4EMAOBALDH1A1
SCHEMBL6331153 0.84 AKR1B1 (0.67) AKR1B1SLC2A1KDM4EMAOBALDH1A1
SCHEMBL29540916 0.84 AKR1B1 (0.67) AKR1B1SLC2A1KDM4EMAOBALDH1A1
SCHEMBL8115506 0.84 SLC2A1 (0.73) AKR1B1SLC2A1KDM4EMAOBALDH1A1
SCHEMBL24496704 0.83 SLC2A1 (0.72) AKR1B1SLC2A1KDM4EMAOBALDH1A1
SCHEMBL8827849 0.83 AKR1B1 (0.78) AKR1B1SLC2A1KDM4EMAOBALDH1A1
SCHEMBL8117451 0.83 AKR1B1 (0.78) AKR1B1SLC2A1KDM4EMAOBMAPT
SCHEMBL10459171 0.82 SLC2A1 (0.71) AKR1B1SLC2A1KDM4EMAOBALDH1A1
SCHEMBL4250015 0.82 AKR1B1 (0.76) AKR1B1SLC2A1KDM4EMAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4761425-A ANTIASTHMATICS; ANTIALLERGENS, ANTIINFLAMMATORY AGENTS MERCK FROSST CANADA, INC. (CA) 1988-08-02 US disclosed
EP-0147217-A2 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1985-07-03 EP disclosed